Humans *Gemcitabine Docetaxel/therapeutic use BCG Vaccine/adverse effects Adjuvants Immunologic *Urinary Bladder Neoplasms/therapy Administration Intravesical Neoplasm Invasiveness Neoplasm Recurrence Local

Humans *BCG Vaccine/adverse effects *Urinary Bladder Neoplasms/drug therapy BCG vaccine administration intravesical systematic review urinary bladder neoplasms

Humans Cystectomy/adverse effects Prospective Studies Quality of Life *Robotics Treatment Outcome *Robotic Surgical Procedures/adverse effects Postoperative Complications/etiology *Urinary Bladder Neoplasms/pathology

Humans *Urinary Bladder Neoplasms/surgery/pathology Urologic Surgical Procedures Cystectomy *Laser Therapy *Lasers Solid-State/therapeutic use Turbt bladder tumor laser resection recurrence

膀胱癌 核基质蛋白22 尿细胞学 Meta分析

Humans Mitomycin/therapeutic use Antibiotics Antineoplastic BCG Vaccine/therapeutic use *Non-Muscle Invasive Bladder Neoplasms Neoplasm Recurrence Local/drug therapy *Urinary Bladder Neoplasms/pathology Administration Intravesical Neoplasm Invasiveness Bladder cancer Device-assisted Emda Intravesical drug administration Nmibc

膀胱肿瘤 膀胱切除术 激光，固体

Bcg Bacillus Calmette–Guérin Nmibc bladder cancer checkpoint inhibition therapy nadofaragene firadenovec non muscle invasive oncolytic viruses

Area Under Curve *Carcinoma Transitional Cell Humans In Situ Hybridization Fluorescence ROC Curve Sensitivity and Specificity *Urinary Bladder Neoplasms/pathology Biomarker Cytology Diagnostic Fluorescent in situ hybridization (FISH) Meta-analysis Upper urinary tract urothelial carcinoma (UTUC)

Bladder cancer neoadjuvant chemotherapy radical cystectomy systematic review variant histology urothelial cancer

Adjuvants Immunologic Administration Intravesical BCG Vaccine/therapeutic use Bayes Theorem *Covid-19 Duration of Therapy Humans *Mycobacterium bovis Neoplasm Invasiveness Neoplasm Recurrence Local/drug therapy Network Meta-Analysis Pandemics *Urinary Bladder Neoplasms/drug therapy *Urology

Humans Female Male *Urinary Bladder Neoplasms/etiology/microbiology RNA Ribosomal 16S/genetics Urinary Bladder/microbiology *Microbiota/genetics Bacteria/genetics Bladder cancer Gender Urinary microbiota Uropathogens of interest.

闭孔神经阻滞 经尿道膀胱肿瘤切除术 椎管内麻醉 腹股沟入路 耻骨入路 Meta分析 随机对照试验

膀胱癌 机器人辅助腹腔镜 腹腔镜 膀胱癌根治术

*Carcinoma Transitional Cell/drug therapy Female Humans Immune Checkpoint Inhibitors/therapeutic use Immunotherapy *Lung Neoplasms/pathology Male Platinum/therapeutic use Programmed Cell Death 1 Receptor *Urinary Bladder Neoplasms/drug therapy

*Cystectomy Humans *Neoadjuvant Therapy Neoplasm Staging Treatment Outcome Urinary Bladder Neoplasms/*drug therapy/pathology/*surgery

Biomarkers Humans Inflammation Prognosis Proportional Hazards Models *Urinary Bladder Neoplasms bladder cancer meta-analysis survival systemic immune-inflammation index commercial or financial relationships that could be construed as a potential conflict of interest.

bladder cancer meta-analysis smoking cessation survival systematic review

*Cystectomy Humans Prospective Studies Systematic Reviews as Topic Treatment Outcome Urinary Bladder/pathology/surgery *Urinary Bladder Neoplasms/pathology/surgery models mortality nomograms radical cystectomy urinary bladder neoplasms

Area Under Curve Female Humans Male Neoplasm Recurrence Local/diagnosis Prospective Studies Recurrence Sensitivity and Specificity *Urinary Bladder Neoplasms/diagnosis Biomarker Bladder cancer Diagnostic accuracy Systematic review Xpert